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Abstract: Aging is commonly deﬁ  ned as the accumulation of diverse deleterious changes 
occurring in cells and tissues with advancing age that are responsible for the increased risk of 
disease and death. The major theories of aging are all speciﬁ  c of a particular cause of aging, pro-
viding useful and important insights for the understanding of age-related physiological changes. 
However, a global view of them is needed when debating of a process which is still obscure 
in some of its aspects. In this context, the search for a single cause of aging has recently been 
replaced by the view of aging as an extremely complex, multifactorial process. Therefore, the 
different theories of aging should not be considered as mutually exclusive, but complementary 
of others in the explanation of some or all the features of the normal aging process. To date, no 
convincing evidence showing the administration of existing “anti-aging” remedies can slow aging 
or increase longevity in humans is available. Nevertheless, several studies on animal models 
have shown that aging rates and life expectancy can be modiﬁ  ed. The present review provides 
an overlook of the most commonly accepted theories of aging, providing current evidence of 
those interventions aimed at modifying the aging process.
Keywords: Aging, anti-aging medicine, caloric restriction, oxidative damage, inﬂ  ammation, 
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Introduction
Aging is commonly deﬁ  ned as the accumulation of diverse deleterious changes occur-
ring in cells and tissues with advancing age that are responsible for the increased risk 
of disease and death (Harman 2003). The observation that most of the animals living 
in a natural environment rarely becomes senescent (because dying earlier for predation, 
disease, starvation, or drought) (Holliday 2006) suggests that aging is a phenomenon 
unique to the human species (Hayﬂ  ick 2000b). In other words, the advancing knowl-
edge of hygiene and biomedicine has led us to discover the aging process, something 
that was teleologically not intended for us to be experienced (Hayﬂ  ick 2000b). The 
immediate consequence of the extended life expectancy is represented by the increas-
ing number of older people in developed countries, an artefact of human civilization 
(Hayﬂ  ick 1998, 2000a). 
Life expectancy is deﬁ  ned as the average total number of years that a human expects 
to live. Differently, life span is the maximum number of years that a human can live. 
While the human life span has substantially remained unchanged for the past 100,000 
years at ~125 years, life expectancy has sensibly increased (~27 years during the last 
century), especially in Western Countries (Hayﬂ  ick 2000b). The lengthening of life 
expectancy is mainly due to the elimination of most infectious diseases occurring in 
youth, better hygiene, and the adoption of antibiotics and vaccines.
Before examining the hypothesized biological factors at the basis of the aging 
process, it is crucial to underline that aging is not a disease. Based on this assump-
tion, Hayﬂ  ick estimates that a potential cure of the leading causes of death in old age Clinical Interventions in Aging 2007:2(3) 402
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(ie, cardiovascular disease, stroke, cancer) would only lead 
to a 15 year-increase in human life expectancy (Hayﬂ  ick 
2000b). Therefore, even in this hypothetical condition, we 
will not become immortal, but we will only be able to expe-
rience how death occurs in the absence of disease. Because 
aging is negatively associated with the ability to respond to 
stress and positively related to the homeostatic balance and 
incidence of pathology, death remains the ultimate conse-
quence of aging (Kowald and Kirkwood 1996).
The notion that aging requires treatment is based on the 
belief that becoming old is undesirable. In the last decades, 
aging has received a negative connotation and become 
synonymous of deterioration, approaching pathology, and 
death. If our society would learn to value old age to the same 
extent as presently done for youth, then the research aimed 
at slowing, stopping or reversing the aging process would be 
as unthinkable as the intervention on the developmental pro-
cesses of youth. Instead, what is desirable and demonstrably 
attainable at all times in life, is the prevention or resolution 
of pathology (Hayﬂ  ick 2004).
The major theories of aging (eg, the free radical theory 
(Harman 2003), the immunologic theory (Franceschi 
et al 2000a), the inﬂ  ammation theory (Chung et al 2001), 
mitochondrial theory (Cadenas and Davies 2000)) are all 
speciﬁ  c of a particular cause of aging, providing useful and 
important insights for the understanding of physiological 
changes occurring with aging. However, a global view of 
them is needed when debating about a process which is still 
obscure in some of its aspects (Holliday 2006). In this context, 
the search for a single cause of aging (such as a single gene or 
the decline of a body system) has recently been replaced by the 
view of aging as an extremely complex, multifactorial process 
(Kowald and Kirkwood 1996; Weinert and Timiras 2003). 
In fact, it is very likely that several processes simultaneously 
interact and operate at different levels of functional organiza-
tion (Franceschi et al 2000b). Therefore, different theories of 
aging should not be considered as mutually exclusive, but may 
be complementary of others to explain some or all the features 
of the normal aging process (Weinert and Timiras 2003).
Throughout history, humans have always dreamed of being 
able to cure aging and diseases, looking for the discovery of 
a “fountain of youth”. This dream has never become reality 
because of the difﬁ  cult understanding of the aging process.   
Any intervention able to delay the development of age-related 
modiﬁ  cations that are not considered as diseases are indicated 
with the term “anti-aging medicine” (Butler et al 2002). To 
date, we know of no intervention that will slow, stop, or 
reverse the aging process in humans. It is also doubtful that 
intervention in the aging process has been achieved in any 
other life form in view of the absence of a generally accepted 
deﬁ  nition of aging and prec  markers to measure its rate of 
change (Hayﬂ  ick 2004). Nevertheless, several studies on ani-
mal models have shown that aging rates and life expectancy 
can be modiﬁ  ed.
Evolutionary theory of aging
Evolutionary theory indicates aging as the result from a decline 
in the force of natural selection. This theory was ﬁ  rst extensively 
formulated in the Forties from the observation of patients with 
Huntington’s disease, a dominant lethal mutation (Haldane 
1941). It was noted that, even if subjects affected by this con-
dition should be strongly selected, the Huntington’s disease 
remained in the population. This lack of natural selection can 
be explained by the late age of onset for the disease (30–40 
years) allowing a carrier to reproduce before dying. 
Even earlier than these observations, Darwin explained 
that a natural selection occurs in organisms dying primarily 
from predation and environmental hazards and consequently 
evolving a life span optimized for their own particular 
environment (Weinert and Timiras 2003). Supporting this 
hypothesis is the evidence that animals living in a protected 
environment (eg, a zoo) live longer, potentially reaching 
their maximum life spans (Holliday 2006). For example, 
this theory was conﬁ  rmed by Austad in a natural environ-
ment by comparing mainland opossums that are subject to 
predation to a population of opossums living on an island 
free of predators (Austad 1993). The evolutionary theory 
predicts that the protected island opossums would have had 
the opportunity to evolve a longer life span, if beneﬁ  cial 
to their ﬁ  tness. Indeed, island opossums did live longer 
and aged more slowly than their mainland counterparts. 
However, the so-called “disposable soma theory of aging” 
argues that the somatic organism is effectively maintained 
only for reproductive success; afterwards it is disposable. 
Therefore, the somatic maintenance (in other words longev-
ity) has a cost. The equilibrium between resources invested 
in longevity versus those for reproductive ﬁ  tness determines 
life span (Loison et al 1999). This antagonism between 
reproduction and longevity is supported by experiments 
in which the limitation of the reproduction by destroying 
germ line cells can extend life span in both Drosophila and 
Caenorhabditis elegans. 
Free radical theory of aging
More than 300 theories have been proposed to explain the 
aging process (Medvedev 1990), but none has yet been Clinical Interventions in Aging 2007:2(3) 403
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generally accepted by gerontologists. Neverthelss, the free 
radical theory of aging seems to be the one receiving the 
widest acceptance as a plausible explanation of the primary 
chemical reactions at the basis of the aging process (De La 
Fuente 2002).
The free radical theory of aging was ﬁ  rst formulated in 
the Fifties by Harman who hypothesized a single common 
process, modiﬁ  able by genetic and environmental factors, 
in which the accumulation of endogenous oxygen radi-
cals generated in cells could be responsible for the aging 
and death of all living beings (Harman 1957; Finkel and 
Holbrook 2000). This theory was then revised in 1972 
(Harman 1972) when mitochondria were identified as 
responsible for the initiation of most of the free radical 
reactions related to the aging process. It was also postulated 
that the life span is determined by the rate of free radical 
damage to the mitochondria. 
The increasing age-related oxidative stress seems to be 
a consequence of the imbalance between the free radical 
production and antioxidant defenses with a higher production 
of the former (Sastre et al 2000). 
All organisms live in an environment that contains 
reactive oxygen species. Mitochondrial respiration, the 
basis of energy production in all eukaryotes, generates 
reactive oxygen species by leaking intermediates from 
the electron transport chain (Finkel and Holbrook 2000). 
The universal nature of oxidative free radicals, and 
possibly of the free radical theory of aging, is suggested 
by the presence of superoxide dismutase in all aerobic 
organisms and responsible for scavenging superoxide 
anions (Finkel and Holbrook 2000). Moreover, cellular 
oxidative damage is indiscriminate. In fact, oxidative 
modifications have been shown to occur in of DNA, 
protein, and lipid molecules (Weinert and Timiras 2003). 
Elevated levels of both oxidant-damaged DNA and 
protein have been found in aged organisms (Beckman 
and Ames 1998; Shringarpure and Davies 2002). 
However, even if it is clear that the age-related accumu-
lation of oxidative damage, it is not yet clear whether this 
process contributes to aging in all organisms. The increased 
life span of transgenic ﬂ  ies expressing superoxide dismutase 
indicates that free radical-scavenging enzymes are sufﬁ  cient 
to delay aging in Drosophila (Tower 2000). Moreover, ﬂ  ies 
selected for increased longevity have elevated levels of 
superoxide dismutase and increased resistance to oxidative 
stress (Arking et al 2000). It has also been demonstrated that 
long-lived mutant worms are also resistant to oxidative stress 
and show an age-dependent increase in superoxide dismutase 
and catalase activity (Larsen 1993). The life span extension in 
Caenorhabditis elegans models by using synthetic molecules 
that mimic catalase and/or superoxide dismutase demon-
strates that antioxidant compounds may play an important 
role in delay aging (Melov et al 2000).
The free radical theory of aging is divided into several 
hypotheses focusing on the exclusive role of particular 
organelles and types of damaged molecules in the aging 
process (Weinert and Timiras 2003). For example, it has 
been hypothesized that mutations in mitochondrial DNA 
accelerate free radical damage by introducing altered en-
zyme components into the electron transport chain. Faulty 
electron transport consequently results in elevated free 
radical leakage and ultimately more mitochondrial DNA 
mutation and exacerbated oxidant production. This “vi-
cious cycle” of mutation and oxidant production may then 
eventually lead to cellular/organ failure, and senescence 
(Mandavilli et al 2002). Another hypothesis argues that 
free radicals cause aging because of the accumulation of 
oxidized proteins in cells. The age-dependent reduction 
in the capacity of degradation of oxidized proteins may 
be responsible for the build-up of damaged, dysfunctional 
molecules in the cell (Shringarpure and Davies 2002). 
It has been suggested that oxidative damage may be an 
important source of somatic mutations at the basis of the 
so-called “somatic mutation theory of aging”. This theory   
hypothesizes that the accumulation of genetic mutations in 
somatic cells represents the speciﬁ  c cause of senescence 
(Beckman and Ames 1998).
The identiﬁ  cation of free radical reactions as promoters 
of the aging process implies that interventions aimed at 
limiting or inhibiting them should be able to reduce the rate 
of formation of aging changes with a consequent reduction 
of the aging rate and disease pathogenesis (Harman 2003). 
An ideal “golden triangle” of oxidative balance, in which 
oxidants, antioxidants and biomolecules are placed at each 
apex, has been described (Carmeli et al 2002). In a normal 
situation, a balanced-equilibrium exists among these three 
elements. Excess generation of free radicals may overwhelm 
natural cellular antioxidant defenses leading to lipid peroxi-
dation and further contributing to muscle damage (Bowles 
et al 1991; Meydani et al 1993). 
Even if antioxidant supplementation is receiving growing 
attention and is increasingly adopted in Western countries, 
supporting evidence is still scarce and equivocal. In fact, 
even if some epidemiological studies shown that dietary 
supplementation with vitamin E decreases the risk of cancer 
and cardiovascular disease, such observations are not universal Clinical Interventions in Aging 2007:2(3) 404
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(Butler et al 2002). The only capability of reducing oxidative 
damage through antioxidant supplementation is limited. McCall 
and Frei (1999) stated that “except for supplemental vitamin E, 
and possibly vitamin C, being able to signiﬁ  cantly lower 
lipid oxidative damage in both smokers and nonsmokers, the 
current evidence is insufﬁ  cient to conclude that antioxidant 
vitamin supplementation materially reduces oxidative damage 
in humans”. Therefore, the longevity-extending potential of 
antioxidant supplementation (in particular, vitamin E as the 
most studied one) remains uncertain even in animal studies 
(Anisimov 2001). The only robust ﬁ  nding that a pharmaco-
logical antioxidant can extend longevity has been reported 
by Melov and colleagues (2000) in an animal model in dem-
onstrating that EUK-134, a compound with both catalase and 
superoxide dismutase activities, signiﬁ  cantly extends longevity 
in nematodes.
Mitochondrial theory of aging
The age-related physiological decline seems to be due to the 
accumulation of defects in the several metabolic pathways. 
Looking for potential candidates to progressive accumu-
lation of damage over a lifetime, it seems reasonable to 
exclude RNA, proteins and other cellular macromolecules 
with a rapid turned over. For this main reason, studies 
exploring mechanisms of aging have always been focused 
on DNA. In mammalian cells, mitochondria and the nucleus 
are the only organelles possessing DNA. It appears obvious 
that the physiological integrity of the cell is strongly linked 
to the integrity of its genome. 
Even if mitochondrial DNA comprises only 1%–3% of 
genetic material in animal cells, its contribution to cellular 
physiology seems to be much greater than what expected 
from its size alone. Mitochondrial DNA, in close proximity 
to the sites of oxygen radical production and unprotected 
by the histones that are associated with nuclear DNA, is 
a sensitive target for oxygen radical attack. In fact, it has 
been estimated that the level of oxydatively oxidized bases 
in mitochondrial DNA is 10- to 20-fold higher than that in 
nuclear DNA (Richter et al 1988; Ames 1989). Moreover, 
mitochondrial DNA encodes polypeptides of the electron 
transfer chain as well as components required for their 
synthesis. Therefore, any coding mutations in mitochon-
drial DNA will affect the entire electron transfer chain, 
potentially altering both the assembly and function of the 
products of numerous nuclear genes in electron transfer 
chain complexes. Finally, defects in the electron transfer 
chain can have pleiotropic effects because affecting the 
entire cellular energetics (Alexeyev et al 2004).
It has been demonstrated by the Framingham Longevity 
Study of Coronary Heart Disease that longevity is more 
strongly associated with age of maternal death than that of 
paternal death, suggesting that mitochondrial DNA inheri-
tance might play an important role in determining longevity 
(Brand et al 1992). Even if the matter is still controversial 
(Ross et al 2001), several studies demonstrate that longevity 
is associated with speciﬁ  c mitochondrial DNA polymor-
phisms (Ivanova et al 1998; Tanaka et al 1998; De Benedictis 
et al 1999).
The mitochondrial theory of aging is often considered 
as an extension and reﬁ  nement of the free radical theory 
(Harman 1972; Miquel et al 1980). Mitochondrial DNA 
mutations accumulate progressively during life and are 
directly responsible for a measurable deﬁ  ciency in cellular 
oxydative phosphorylation activity, leading to an enhanced 
reactive oxygen species production. This latter results 
in an increased rate of mitochondrial DNA damage and 
mutagenesis, triggering the onset of a “vicious cycle” of 
exponentially increasing oxidative damage and dysfunc-
tion, which ultimately culminates in death. Supporting the 
primary importance of mitochondria in the aging process 
and in determining longevity, it has been documented that 
several mutagenic chemicals and lipophilic carcinogens (eg, 
polycyclic aromatic hydrocarbons) tend to preferentially 
damage mitochondrial DNA (Wunderlich et al 1970; Allen 
and Coombs 1980; Niranjan et al 1982; Rossi et al 1988). It 
can then be hypothesized that a life-long exposure to these 
environmental toxins may lead to a preferential accumulation 
of mitochondrial DNA damage and accelerate aging. 
The superoxide anion radical (or superoxide) and hydro-
gen peroxide, respectively the products of the univalent and 
bivalent reduction of oxygen, are produced during normal 
aerobic metabolism and constitute physiological intracellular 
metabolites (Cadenas and Davies 2000). Several reactions 
in biological systems contribute to the steady state concen-
trations of superoxide and hydrogen peroxyde, although 
mitochondria seem to be quantitatively the most important 
source (Cadenas and Davies 2000). 
Although mild amounts of oxidative damage such as 
that experienced during exercise training (Davies et al 1982) 
may actually be the stimulus for physiological mitochondrial 
biogenesis, more severe, more extensive, or more prolonged 
oxidative damage is clearly toxic (Cadenas and Davies 2000).
Gene regulation theory of aging
The gene regulation theory of aging proposes that senes-
cence is the resulting of changes occurring in the gene Clinical Interventions in Aging 2007:2(3) 405
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expression (Kanungo 1975; Weinert and Timiras 2003). 
Although it is clear that many genes show changes in 
expression with age, it is unlikely that selection could act 
on genes that promote senescence directly (Weinert and 
Timiras 2003). To date, evidence in this ﬁ  eld remains con-
troversial, and aging should be more safely considered as a 
stochastic process, rather than a programmed mechanism 
directly governed by genes. At least 15 different genetic 
manipulations inducing life extension in organisms such 
as yeast, fruit ﬂ  ies, nematodes, and mice have been dem-
onstrated (Butler et al 2002). However, it is still unknown 
how the proteins coded by these genes are acting in the 
regulation of longevity. On the other hand, other studies 
performed using animal models have suggested that genes 
supposed to be involved in aging are not able to reverse or 
arrest the inexorable expression of the molecular disorder 
that is the hallmark of aging (Hayﬂ  ick 2004). 
It may be that the genome is necessary to govern bio-
logical development and maintenance, but unnecessary to 
cause the animal’s aging. Because genes do not drive the 
aging process, an understanding of the human genome, 
even beyond what is known today, will not provide insights 
into a process that is random and thermodynamically driven 
(Hayﬂ  ick 2004). Recently, an insulin-like signaling pathway 
regulating life span in worms, ﬂ  ies, and mice has been identi-
ﬁ  ed (Tatar et al 2003). Life span extension results from the 
activation of a conserved transcription factor in response to 
a reduction in insulin-like signaling, suggesting that gene 
expression can regulate life span. 
Studies of human centenaries and their relatives have 
identiﬁ  ed a signiﬁ  cant genetic aspect of the ability to survive 
to exceptional ages. By identifying a locus on chromosome 
4 that may contain gene(s) promoting longevity (Puca et al 
2001), it has recently been supported the theory of a genetic 
component for exceptional longevity.
If it will be conﬁ  rmed that changes in gene expression 
can modulate the aging process, a major step forward the 
understanding of aging will be completed and a starting 
point for the development of interventions aimed at delaying 
aging provided. 
Gene manipulations possible in laboratory animals appear 
to have limited potential for direct application in humans, 
although they do provide insight into important biological 
factors in longevity determination in model systems. In con-
trast, the potential of cell replacement therapy in reversing 
some of the adverse effects of aging appears to be substantial. 
Aging is accompanied by some loss of tissue function, which 
is at least partially due to either the age-related loss of cells 
from the tissue or an increased proportion of dysfunctional 
cells. 
The recent isolation of nearly totipotent cells, such as 
human embryonic stem cells, offers a great range of potential 
opportunities. These cells express telomerase and appear to 
maintain an immortal phenotype even after extended culture 
in vitro. Cells and tissues derived from such cultures may 
provide the unique advantage of possessing a large replicative 
capacity and broad differentiation potential.
However, it is important to note that formidable hurdles 
are yet to be overcome. Cells derived from established human 
embryonic stem cell lines will probably not prove to be 
immunologically compatible with most patients. This may 
be resolved by immunosuppressive therapy, genetic modi-
ﬁ  cation of the cells to reduce immunogenicity, or possibly 
the creation of a chimeric immune system in the patient to 
induce tolerance. The recent discovery of cell reprogramming 
through nuclear transfer offers a path to the reprogramming 
of a patient’s cell, thereby reverting it to an autologous 
embryonic stem cell. The ethics of the embryonic stem cell 
technology and the use of nuclear transfer in medicine is 
currently a matter of intense debate. Finally, it remains to 
be seen whether such new tissue (even if it were autologous) 
would be adequately vascularized and subsequently function 
appropriately in the patient.
Telomere theory of aging
The cellular senescence theory of aging was formulated in 
1965 when cell senescence was described as the process 
occurring in normal human cells in culture and characterized 
by a limited number of cell divisions (Hayﬂ  ick 1965). This 
limit in “replicative capacity” occurs after a characteristic 
number of cell divisions and results in terminally arrested 
cells with altered physiology (Campisi 2003). 
Telomeres are specialized DNA sequences located at 
the ends of eukariotic chromosomes. In humans, telomeres 
are composed by repeated sequences TTAGGG reiterated 
in tandem for up to 15 kilobases at birth (Ahmed and 
Tollefsbol 2001). Telomeres are synthesized by telomer-
ase, a ribonucleoprotein reverse transcriptase enzyme that 
maintains the lengths of chromosomes (Lingner et al 1997). 
Telomere sequences stabilize chromosomal ends by bind-
ing to proteins that prevent them from being recognized 
as double-stranded breaks by repair enzymes (de Lange 
1992). The attrition of chromosomal termini, caused by 
loss of telomerase, can lead to breaks and subsequent 
translocation, fusion, or rearrangement within these DNA 
regions (de Lange 1992).Clinical Interventions in Aging 2007:2(3) 406
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The telomerase enzyme, which stabilize chromosomal 
termini by adding telomere repeats to the ends of chro-
mosomes using a dedicated RNA template (Greider and 
Blackburn 1989; Artandi 2006), is of considerable interest 
to gerontologists. Its expression is thought to be necessary 
for cellular immortalization (Rhyu 1995), and its absence 
may constitute a fundamental basis for cellular aging (Harley 
et al 1990; Ahmed and Tollefsbol 2001; Artandi 2006). 
Immortal cells in general have a stable telomere length 
and mortal cells have telomeres that shorten with each cell 
division, thus establishing a link between the presence of 
telomerase, chromosomal stability, and the mortality of cells. 
In fact, specialized immortal cell types (such as stem cells, 
germ cells, and T lymphocytes) express telomerase and will 
either maintain telomere length or delay telomere attrition. 
Additionally, telomerase is up-regulated in 85% to 95% of 
cancer cells, which show no net loss of average telomere 
length, suggesting that telomere stability may be required 
for cells to escape replicative senescence and to proliferate 
indeﬁ  nitely (Shay and Wright 1996; Artandi 2006). 
In actively dividing differentiated cells, with each cell 
division, a small amount of DNA is necessarily lost at each 
chromosome end, resulting in ever-shorter telomeres and 
altered telomere structure, eventually leading to the cessa-
tion of cellular proliferation (Blackburn 2000; Weinert and 
Timiras 2003). This progressive shortening of telomeres 
starts soon after conception, when cells begin widespread 
differentiation. Although in some of these cells telomerase 
is inactivated before birth, in others some telomerase activity 
can be detected after birth (Ulaner and Giudice 1997; Ahmed 
and Tollefsbol 2001). Thus, telomere shortening and the loss 
of telomerase in normal somatic cells have been implicated 
as a potential molecular clock triggering cellular senescence 
(Harley et al 1990), loss of proliferative capacity, and age-
related pathologies (Campisi 1997; Fossel 1998).
The ﬁ  nding that most of the cells expressing telomerase, 
instead of undergoing cellular aging, maintain a youthful 
state and proliferate indeﬁ  nitely has opened new ﬁ  elds of re-
search for a potential “anti-aging” intervention (Bodnar et al 
1998; Vaziri and Benchimol 1998). Cells that have been 
supplied with an exogenous source of telomerase maintain 
a youthful state and proliferate indeﬁ  nitely (Bodnar et al 
1998). These “rejuvenated” cells are not only immortal, but 
they have also shown reversal of senescent characteristics 
(such as increased fragility and subepidermal blistering) 
(Funk et al 2000). Thus, the biological and potential medical 
consequences of telomerase expression appear to be highly 
signiﬁ  cant. 
Supporting the hypothesized relationship between 
telomeres and aging, it has been demonstrated that some 
telomere dysfunctions are involved in the premature aging 
characteristic of progerias. For example, the DNA helicase 
protein, that is mutant in the Werner’s syndrome, is required 
for the efﬁ  cient replication and stability of telomeres. There-
fore, by extension, as it happens in the premature aging, 
telomeres might be, at least partially, responsible for the 
normal human aging (Artandi 2006).
The human telomerase reverse transcriptase (hTERT), 
the active component of telomerase, has been identiﬁ  ed and 
cloned and its messenger RNA is undetectable in differenti-
ated cells that do not express telomerase, but is abundant 
in undifferentiated cells expressing telomerase (Meyerson 
et al 1997). Although post-transcriptional mechanisms 
may modify hTERT activity (Liu et al 1999), the expres-
sion of hTERT correlates directly with telomerase activity 
and substantial evidence indicates that hTERT activity is 
controlled primarily at the level of transcription (Cong et al 
1999; Wick et al 1999). The telomerase promoter must be 
“ON” in cells that can proliferate indeﬁ  nitely, but “OFF” in 
cells with limited proliferative lifespan. Unfortunately, little 
is still known about the switching mechanism that controls 
telomerase expression, leading to its down-regulation and 
subsequent cellular mortality in somatic cells. 
Moreover, even if studies of telomere shortening and 
telomerase show great promise in helping to elucidate the 
underlying basis of cellular aging, it is not yet clear how 
this knowledge would enhance our understanding of aging 
of the individual. In fact, it is possible the presence of 
some tissues in which proliferative failure contributes to 
the declining physiology associated with aging, but those 
tissues have not been unequivocally identiﬁ  ed. Only up 
to 70% of immortalized human somatic cell lines (Bryan 
et al 1997) and about 90% of human cancer cell lines (Shay 
and Gazdar 1997) have demonstrated in vitro telomerase 
activity, suggesting that factors other than telomerase are 
involved in cell replication and senescence. Moreover, many 
telomerase-negative immortalized cell lines can maintain 
their telomere lengths (Bryan et al 1995). On the other hand, 
hybrids of telomerase-negative and telomerase-positive 
cells have failed to become immortal, so that it is likely 
that telomerase enzyme alone is insufﬁ  cient to prevent cell 
senescence (Bryan et al 1995).
Although studies to this point indicate that telomerase 
may be intimately involved in cellular senescence and 
holds great promise, our understanding of these age-related 
mechanisms is still at the beginning. The amount of Clinical Interventions in Aging 2007:2(3) 407
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currently available evidence for claiming that preventing 
telomere shortening would inﬂ  uence any aspect of aging 
is still insufﬁ  cient.
Inﬂ  ammation hypothesis of aging
Even if the involvement of the inﬂ  ammatory process in 
several (sub)clinical conditions (eg, atherosclerosis, diabetes, 
dementia) is well-demonstrated, the importance of inﬂ  am-
mation in the aging process was recognized only recently 
(McGeer and McGeer 1999; Chung et al 2001). Nevertheless, 
inﬂ  ammation is growingly considered as a cornerstone of the 
mechanisms underlying the aging process, so to even gener-
ate the neologism “inﬂ  amm-aging” (Franceschi et al 2000a). 
Inﬂ  ammation is a complex host’s normal defense reaction 
to physiological and nonphysiological stressors. Acute as 
well as chronic inﬂ  ammatory responses are constituted by 
sequential phases, controlled by humoral and cellular stimula: 
1) intracellular activation; 2) proinﬂ  ammatory cells in the 
tissues; 3) increase of vascular permeability; 4) damaging 
of tissues and cell death (Huerre and Gounon 1996; Chung 
et al 2001). 
An individual threshold of the capability to cope with 
stress has been hypothesized. If the age-related inﬂ  amma-
tion (or inﬂ  amm-aging) trespasses this level, the transition 
between successful and unsuccesful aging occurs. Epidemio-
logic data support the hypothesis that the period of life during 
unsuccessful aging (disability) is maximal in the elderly, 
and minimal in young people and centenarians (Franceschi 
et al 2000a).
Even when debating about inﬂ  ammation and its relation-
ship with aging, it is important to underline how this mecha-
nism is associated with others at the basis of different theories 
of aging. In fact, the close relationship between inﬂ  ammation 
and oxidative damage is well-known in literature (Cesari et al 
2005). In fact, reactive oxygen species and reactive nitrogen 
species are heavily implicated in the inﬂ  ammatory processes. 
The overproduction or uncontrolled release of reactive spe-
cies is a major causative factor in tissue inﬂ  ammation.
Immune theory of aging
In 1989, Franceschi proposed the immune theory of aging, or 
network theory of aging (Franceschi 1989; Franceschi et al 
2000a), in which suggested that aging is indirectly controlled 
by a network of cellular and molecular defense mechanisms. 
The major parts of the network are constituted by DNA repair 
enzymes, activation of poly (ADP-ribosyl) polymerase, enzy-
matic and nonenzymatic antioxidant systems (eg, superoxide 
dismutase, catalase, glutathione peroxidase), production of 
heat shock proteins (Franceschi 1989; Franceschi et al 2000b). 
These mechanisms function to limit the negative effects of a 
variety of physical, chemical, and biological stressors. The 
efﬁ  ciency of the network is genetically controlled and differs 
among species and individuals, explaining in this way the 
observed differences in life span. 
In the network theory of aging, the immune system 
represents the most powerful mechanism to face stressors 
(Franceschi et al 2000a). In particular, Franceschi identiﬁ  ed 
the macrophage as the primary modulator of the vicious cycle 
existing between innate immunity, inﬂ  ammation and stress. 
The macrophage activation due to chronic stress may provide 
a potential explanation to the subclinical chronic inﬂ  amma-
tory status characterizing older persons and, at the same time, 
a possible feature of the aging process. Lymphocytes are also 
affected by the continuous age-related antigenic stress, result-
ing in a chronic stimulation responsible for the expansion of 
memory cells, the decrease (even exhaustion) of naïve cells, 
and the shrinkage of the T-cell repertoire.
Supporting this hypothesis and the importance of the 
immune system in determining the senescence is the evidence 
of the high incidence of tumors and greater susceptibility 
to infections from pathogens shown by the older persons. 
It has been suggested that aged subjects maintaining their 
immune functions at an exceptionally high level are more 
likely to have a long life span (Wayne et al 1990; Pawelek 
et al 1999).
As noted above, theories of aging often overlap each 
other, suggesting interactions across different systems and 
mechanisms. In this context it should be considered the 
association between the immune cell functions (such as 
those involved in the cytotoxic activity and particularly 
in phagocytes as regards their microbicidal activity) and 
the reactive oxygen species generation. The excessive 
amount of reactive oxygen species not counteracted by the 
antioxidant defenses can become a potential source of tis-
sue damage (De La Fuente 2002). Moreover, antioxidants 
maintain the integrity and function of membrane lipids, 
cellular proteins, and nucleic acids and the control of sig-
nal transduction of gene expression in immune cells. Not 
surprisingly, immune system cells usually contain higher 
concentrations of antioxidants than do other cells (Knight 
2000), given the high percentage of polyunsatured fatty 
acids in their plasma membranes. Thus, the immune cell 
functions are strongly influenced by the antioxidant/
oxidant balance and, therefore, the antioxidant levels 
play a pivotal role in maintaining immune cells I) in a 
reduced environment and II) in protecting them from Clinical Interventions in Aging 2007:2(3) 408
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oxidative stress, so to preserve their adequate function-
ing (Knight 2000). 
Neuroendocrine theory of aging
It is generally accepted a bidirectional communication 
between the nervous and the immune systems (Besedovsky 
and Del Rey 1996). With aging not only a functional decline 
in the immune and nervous systems occurs, but also an 
impaired relationship between these two regulatory systems 
can become evident, with the resulting loss of homeostasis 
and higher risk of death (Fabris 1991; De La Fuente 2002).
The neuroendocrine theory proposes that aging is due to 
changes in neural and endocrine functions that are crucial 
for:1) coordination and responsiveness of different systems 
to the external environment; 2) programming physiological 
responses to environmental stimuli; and 3) the maintenance of 
an optimal functional status for reproduction and survival. 
These changes, not only selectively affect neurons and 
hormones regulating evolutionarily signiﬁ  cant functions such 
as reproduction, growth, and development, but also inﬂ  u-
ence the regulation of survival through adaptation to stress. 
Thus, the life span, regulated by “biological clocks”, would 
undergo a continuum of sequential stages driven by nervous 
and endocrine signals. Alterations of the biological clock (eg, 
reduced responsiveness to the stimuli regulating the clock, 
excessive or insufﬁ  cient coordination of responses) would 
disrupt the clock and the corresponding adjustments (Finkel 
1976; Timiras 1978; Weinert and Timiras 2003). 
An important component of this theory indicates the 
hypothalamo-pituitary-adrenal (HPA) axis as the primary 
regulator, a sort of pacemaker signaling the onset and ter-
mination of each stage of life. The HPA axis controls the 
physiological adjustments aimed at the preservation and 
maintenance of an internal homeostasis despite the continu-
ing changes in the environment (Weinert and Timiras 2003). 
During life span, chronic exposure to severe and multiple 
physical, biological, or emotional stressors may exhaust or 
weaken this capacity to adapt and to the so-called “disease 
of adaptation” and death (Selye 1976; Weinert and Timiras 
2003). Aging should then be considered as the result of a 
decrease ability to survive stress, suggesting once more the 
close relationship between stress and longevity. 
The integration of responses to environmental stimuli 
seems to be carried out by hypothalamus from information 
derived in various cerebral structures. The hypothalamus 
itself regulates: 1) nervous functions (eg, sympathetic and 
parasympathetic visceral functions), 2) behaviors (eg, sexual 
and eating behavior, rage, fear), and 3) endocrine functions 
(eg, production and secretion of hypophysiotropic hormones 
stimulating/inhibiting hormone release from the hypophysis). 
In response to hypothalamic signals, the hypophysis produces 
and secrets several hormones acting in the regulation of many 
important functions of the body. This regulation is controlled 
by the release of hormones (eg, growth hormone, oxytocin, 
vasopressin) or by the stimulation of peripheral endocrine 
glands (eg, adrenal cortex, thyroid, gonads). 
Major hormones of the adrenal medulla are the catecola-
mines epinephrine and norepinephrine, functioning as neu-
rotransmitters for the sympathetic division of the autonomic 
nervous system and rapidly responding to any external or 
internal stress through circulatory and metabolic adjustments 
(Weinert and Timiras 2003). With aging, a reduction in 
sympathetic responsiveness is characterized by: 1) a lower 
number of catecholamine receptors in peripheral target tis-
sues; 2) a decline of heat shock proteins that increase stress 
resistance;  and 3) a decreased capability of catecholamines 
to induce heat shock proteins. 
The hormones of the adrenal cortex are glucocorticoids 
(responsible for the regulation of lipid, protein, and carbo-
hydrate metabolism), mineralcorticoids (regulating water 
and electrolytes), and sex hormones. Among the latter is 
dehydroepiandrosterone, which has shown to decrease with 
aging.
 Dehydroepiandrosterone replacement therapy has been 
advocated in humans, despite unconvincing results (Daynes 
and Araneo 1992). Glucocorticoids, as well as other steroid 
hormones, are regulated by positive and negative feedbacks 
between the target hormones and their central control by the 
hypophysis and hypothalamus. With aging and in response 
to chronic stress, not only feedback mechanisms may be 
altered, but also glucocorticoids themselves become toxic to 
neural cells, thus disrupting feedback control and hormonal 
cyclicity (Sapolsky et al 1986; Sapolsky 1992; Weinert and 
Timiras 2003).
The circulating levels of growth hormone, testosterone, 
estrogen, dehydroepiandrosterone, and other hormones 
decrease with age. Although some hormone replacement 
strategies have been shown in clinical trials to modify some 
of physiological attributes associated with aging, negative 
side effects occur frequently with those interventions shown 
to have some beneﬁ  t, such as growth hormone. 
Although the epidemiological data are overwhelm-
ingly positive regarding some health beneﬁ  ts of estrogen 
replacement therapy, a recent study has raised a concern 
about ovarian cancer after long-term use. It has been shown 
that melatonin supplementation increases the mean life Clinical Interventions in Aging 2007:2(3) 409
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expectancy of mice by approximately 5%, but in association 
with an increase in spontaneous tumor incidence.
In order to adequately address hormone decline 
occurring with aging, it is crucial the understanding of 
the complex hormonal cascade, an intricate interplay 
between signals, pathways, and production and delivery 
systems. 
Estrogen replacement therapy represents a special case 
of hormone replacement therapy and deserves particular 
attention because of its long clinical history and apparent 
record of success in increasing quality of life in postmeno-
pausal women. Estrogen is particularly recommended for 
the prevention of osteoporosis, but it has been suggested it 
may reduce the risk of dementia and cardiovascular disease. 
It has been estimated that favorable changes in plasma lipids 
may account for approximately 25% of the cardioprotective 
effect of estrogen. 
The conclusion that estrogen protects postmenopausal 
women against cardiovascular disease is now being ques-
tioned, based mainly on experiments examining secondary 
prevention in women with preexisting heart disease.
Estrogen replacement therapy has been called the ﬁ  rst 
true anti-aging therapy. However, no results have yet been 
reported of randomized studies that compare effects of this 
therapy with placebos, beginning at the menopausal transi-
tion, in women with no known preexisting coronary heart 
disease or dementia.
It has been demonstrated that circulating levels of 
growth hormone drop with increasing age. It has also 
been shown that GH replacement in adults with pituitary 
disease and GH deﬁ  ciency has beneﬁ  cial effects on body 
composition, reducing fat and increasing lean body mass, 
muscle strength, and bone mass. Rudman and colleagues 
investigated whether GH injections in older men would 
restore muscle mass typical of younger men. They found 
that insulin growth factor (IGF)-1 levels did rise and 
that lean body mass increased while fat mass decreased, 
suggesting that GH injections did reverse the changes in 
body composition that were due to age and decondition-
ing. Recent data obtained with mice suggest that lifelong 
overproduction of GH reduces longevity in mice, whereas 
underproduction or an inability to respond to GH increases 
it. Transgenic mice overexpressing GH exhibit severe 
kidney lesions and increased incidence of neoplasms, and 
overproduction of GH in adult humans leads to a condition 
known as acromegaly, which is characterized by excessive 
growth of certain organs and tissues, but also premature 
heart and lung failure.
The evidence from both nematodes and fruit flies 
suggests that decreased activity of the insulin-like signaling 
pathway is associated with increased life expectancy, rather 
than the reverse. Thus, further research is needed before 
the GH supplementation in humans encouraged by many 
“antiaging” clinicians can be considered either safe or useful 
for long-term intervention.
Neuroendocrine-immuno theory 
of aging
In the hierarchy of multisystem regulation throughout the 
sequential stages of life, there is a signiﬁ  cant role for the 
interaction and integration of the neuroendocrine and immune 
systems. Such interaction occurs through 1) neuropeptides 
and cytokines present in the immune system mediating both 
intraimmune communication and between the neuroendo-
crine and immune systems, 2) several hormones from the 
posterior (vasopressin) and anterior (thyroid-stimulating 
hormone, prolactin, adrenocorticotropic hormone, growth 
hormone) hypophysis, and 3) reciprocal action of cytokines 
on neuroendocrine functions. 
Besides of neuroendocrine interactions, the immune 
system must control and eliminate foreign organisms and 
substances in the host body while at the same time recogniz-
ing, and therefore sparing from destruction, the molecules 
from oneself. In most older persons, immunosenescence is 
characterized by a decreased resistance to infectious diseases, 
a decreased protection against cancer, and an increased 
failure to recognize self (leading to consequent autoimmune 
pathology) (Franceschi et al 2000b). Both the neuroendocrine 
and immune systems are characterized by a high degree of 
plasticity and are able to modify their functioning accord-
ing to demand. Plasticity is most efﬁ  cient at early ages, but 
persists at advanced age. 
To describe the theoretical trajectories of the aging pro-
cess, Rowe and Kahn (1987) described three curves: the ﬁ  rst 
characterized by disease and disability; the second, known as 
“usual aging”, characterized by absence of overt pathology 
but presence of some decline in function; and the last, the 
so-called “successful aging”, with little or no physiological 
loss and no pathology. Mechanisms of successful aging are 
based on: 1) persistence of normal function and plasticity, 
2) compensatory responses to restore normal function, 3) 
interventions to replace deﬁ  cient functions, 4) changing of 
health outcome by modifying risk proﬁ  les, 5) prevention 
of disease, and 6) strengthening of social interactions and 
support (Rowe and Kahn 1998). It has been postulated that 
a successful example of this “functional remodeling” may be Clinical Interventions in Aging 2007:2(3) 410
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mediated by neuroendocrine and immune systems (Mobbs 
et al 2001). 
Caloric restriction
A single chapter in this review is deserved by caloric restric-
tion, the only nongenetic intervention that has consistently 
shown to slow the intrinsic rate of aging in mammals (Dirks 
and Leeuwenburgh 2006). It is deﬁ  ned by the reduction in 
caloric intake while maintaining essential nutrient require-
ments. Traditionally, experimental mammalian models of 
caloric restriction reduce caloric intake by ~40% of the 
adlibitum diet throughout the lifespan of the animal. This 
reduction has resulted in a 30%–40% increase in maximum 
lifespan (Weindruch et al 1986). 
How is caloric restriction able to increase lifespan? It is 
likely that this intervention can obtain beneﬁ  cial effects by 
acting at various levels of function and involving a number 
of molecular cellular, and systemic changes. Not only 
is longevity increased, but also metabolic (eg, increased 
tissue sensitivity to insulin), neuroendocrine and immune 
(eg, increased defenses against stress, infections, cancer), 
and collagen responses (eg, reduction of cross-linking) are 
signiﬁ  cantly enhanced (Mobbs et al 2001). It is noteworthy 
that such functional changes might also be modulated by 
changes in gene expression proﬁ  le. Caloric restriction may 
promote longevity by a metabolic reprogramming with a 
transcriptional shift (perhaps triggered by insulin) toward 1) 
reduced energy metabolism, and 2) increased biosynthesis 
and turnover of proteins. It has also been demonstrated that 
caloric restriction markedly inﬂ  uences the expression of 
pathological phenotypes in rodent species selectively bred as 
models of human pathology (Weinert and Timiras 2003).
Even if the short-term effects in humans are promising 
(Walford et al 1999; Weyer et al 2000; Fontana et al 2004), 
long-term studies are not surprisingly difﬁ  cult to conduct in 
humans. The lack of data from human models is mainly due 
to the difﬁ  culties of adhering to this rigorous intervention 
and the length of the human life span. 
The most famous reports about the effects of caloric 
restriction on humans’ health were obtained from the 
Biosphere 2 experiments. Biosphere 2 is a closed ecological 
space located in the deserts of Arizona. In 1991, eight individ-
uals entered the biosphere for a two-year period to study the 
effects from living in a closed system. Because of unexpected 
technical problems, the access to food was limited for the 
entire duration of the study, so that the actual caloric intake 
of the participants was approximately 30% lower than what 
expected. Physiological and biochemical measurements were 
assessed over the time spent inside the biosphere (ie, while 
crew members experienced caloric restriction) as well as 
18 months after exiting the biosphere and returning to their 
normal diets. The physiological modiﬁ  cations experienced 
by the Biosphere 2 participants were similar to those found in 
caloric restricted rodents and nonhuman primates: decline in 
metabolic rate, body temperature, and systolic and diastolic 
blood pressure, and reductions in blood glucose, insulin, and 
thyroid hormone levels.
It has been shown that the Okinawan population is 
characterized by reduced morbidity and mortality, and the 
greatest percentage of centenarians in the world lives in this 
island. It has been hypothesized that the long disability-free 
life expectancy of this population might be due to the diet, 
based on vegetables, grains, soy, fruits, ﬁ  sh and seaweed, and 
characterized by a low caloric intake (~20% less than the rest 
of Japan and ~40% less than United States). It is noteworthy 
that this diet is very similar to the caloric restriction interven-
tions designed for experiments in animal models. 
Despite of the abundant data showing health beneﬁ  ts and 
the reduction of the aging rate by use of a caloric restriction 
intervention in mammalian animal models, it is likely that 
these beneﬁ  cial effects will be lost in the translation to human 
models (Dirks and Leeuwenburgh 2006). Consequently, the 
previous great expectations about long-term caloric restric-
tion in humans as the new “fountain of youth” have recently 
been resized.
Conclusion
It has been argued that more than half of the budget of the 
US National Institute on Aging is spent on Alzheimer’s 
disease (Hayﬂ  ick 2000a). Nevertheless, the elimination of 
this clinical condition will have only a minimal impact on life 
expectancy and will not help the advancing of our knowledge 
of fundamental biology of aging. Greater attention has to 
be given to a rarely posed question: why are old cells more 
vulnerable to disease than young cells? The answer to this 
issue will not only advance our fundamental knowledge of 
aging, but also promote the understanding of age-related 
diseases (Hayﬂ  ick 2000a).
Several and important step forward the understanding 
of the aging process have been done, so that it is no more 
an obscure issue of biology (Holliday 2006). Nevertheless, 
further studies are still needed and numerous cues solved. 
In particular, it is important to clarify to which extent and 
at which price the aging process can be limited or reversed. 
In pursuing a solution to these issues, we should keep clear 
in mind what Hayﬂ  ick wrote in a Nature commentary: “If Clinical Interventions in Aging 2007:2(3) 411
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the main goal of our biomedical research enterprises is to 
resolve causes of death, then every old person becomes a 
testimony to those successes. Biogerontologists have an 
obligation to emphasize that the goal of research on ageing 
is not to increase human longevity regardless of the conse-
quences, but to increase active longevity free from disability 
and functional dependence” (Hayﬂ  ick 2000b).  
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